174 related articles for article (PubMed ID: 23226420)
1. Effects of the small molecule HERG activator NS1643 on Kv11.3 channels.
Bilet A; Bauer CK
PLoS One; 2012; 7(11):e50886. PubMed ID: 23226420
[TBL] [Abstract][Full Text] [Related]
2. Strong activation of ether-à-go-go-related gene 1 K+ channel isoforms by NS1643 in human embryonic kidney 293 and Chinese hamster ovary cells.
Schuster AM; Glassmeier G; Bauer CK
Mol Pharmacol; 2011 Nov; 80(5):930-42. PubMed ID: 21856740
[TBL] [Abstract][Full Text] [Related]
3. Differential effects of Kv11.1 activators on Kv11.1a, Kv11.1b and Kv11.1a/Kv11.1b channels.
Larsen AP; Bentzen BH; Grunnet M
Br J Pharmacol; 2010 Oct; 161(3):614-28. PubMed ID: 20880400
[TBL] [Abstract][Full Text] [Related]
4. Mechanism of action of a novel human ether-a-go-go-related gene channel activator.
Casis O; Olesen SP; Sanguinetti MC
Mol Pharmacol; 2006 Feb; 69(2):658-65. PubMed ID: 16284303
[TBL] [Abstract][Full Text] [Related]
5. The human ether-a-go-go-related gene activator NS1643 enhances epilepsy-associated KCNQ channels.
Li P; Chen X; Zhang Q; Zheng Y; Jiang H; Yang H; Gao Z
J Pharmacol Exp Ther; 2014 Dec; 351(3):596-604. PubMed ID: 25232191
[TBL] [Abstract][Full Text] [Related]
6. NS1643 enhances ionic currents in a G604S-WT hERG co-expression system associated with long QT syndrome 2.
Huo J; Guo X; Lu Q; Qiang H; Liu P; Bai L; Huang CL; Zhang Y; Ma A
Clin Exp Pharmacol Physiol; 2017 Nov; 44(11):1125-1133. PubMed ID: 28741726
[TBL] [Abstract][Full Text] [Related]
7. Potent activation of large-conductance Ca2+-activated K+ channels by the diphenylurea 1,3-bis-[2-hydroxy-5-(trifluoromethyl)phenyl]urea (NS1643) in pituitary tumor (GH3) cells.
Wu SN; Peng H; Chen BS; Wang YJ; Wu PY; Lin MW
Mol Pharmacol; 2008 Dec; 74(6):1696-704. PubMed ID: 18809671
[TBL] [Abstract][Full Text] [Related]
8. Activation of human ether-a-go-go-related gene potassium channels by the diphenylurea 1,3-bis-(2-hydroxy-5-trifluoromethyl-phenyl)-urea (NS1643).
Hansen RS; Diness TG; Christ T; Demnitz J; Ravens U; Olesen SP; Grunnet M
Mol Pharmacol; 2006 Jan; 69(1):266-77. PubMed ID: 16219910
[TBL] [Abstract][Full Text] [Related]
9. Kinetic model for NS1643 drug activation of WT and L529I variants of Kv11.1 (hERG1) potassium channel.
Perissinotti LL; Guo J; De Biase PM; Clancy CE; Duff HJ; Noskov SY
Biophys J; 2015 Mar; 108(6):1414-1424. PubMed ID: 25809254
[TBL] [Abstract][Full Text] [Related]
10. Activation of ERG2 potassium channels by the diphenylurea NS1643.
Elmedyb P; Olesen SP; Grunnet M
Neuropharmacology; 2007 Aug; 53(2):283-94. PubMed ID: 17610913
[TBL] [Abstract][Full Text] [Related]
11. Effects of Temperature on Heteromeric Kv11.1a/1b and Kv11.3 Channels.
Mauerhöfer M; Bauer CK
Biophys J; 2016 Aug; 111(3):504-523. PubMed ID: 27508435
[TBL] [Abstract][Full Text] [Related]
12. Probing the binding sites and mechanisms of action of two human ether-a-go-go-related gene channel activators, 1,3-bis-(2-hydroxy-5-trifluoromethyl-phenyl)-urea (NS1643) and 2-[2-(3,4-dichloro-phenyl)-2,3-dihydro-1H-isoindol-5-ylamino]-nicotinic acid (PD307243).
Xu X; Recanatini M; Roberti M; Tseng GN
Mol Pharmacol; 2008 Jun; 73(6):1709-21. PubMed ID: 18372399
[TBL] [Abstract][Full Text] [Related]
13. Inverse Modulation of Neuronal K
Dierich M; Evers S; Wilke BU; Leitner MG
Front Mol Neurosci; 2018; 11():11. PubMed ID: 29440988
[TBL] [Abstract][Full Text] [Related]
14. NS1643 interacts around L529 of hERG to alter voltage sensor movement on the path to activation.
Guo J; Cheng YM; Lees-Miller JP; Perissinotti LL; Claydon TW; Hull CM; Thouta S; Roach DE; Durdagi S; Noskov SY; Duff HJ
Biophys J; 2015 Mar; 108(6):1400-1413. PubMed ID: 25809253
[TBL] [Abstract][Full Text] [Related]
15. Structure-guided topographic mapping and mutagenesis to elucidate binding sites for the human ether-a-go-go-related gene 1 potassium channel (KCNH2) activator NS1643.
Durdagi S; Guo J; Lees-Miller JP; Noskov SY; Duff HJ
J Pharmacol Exp Ther; 2012 Aug; 342(2):441-52. PubMed ID: 22573844
[TBL] [Abstract][Full Text] [Related]
16. Computational analysis of the effects of the hERG channel opener NS1643 in a human ventricular cell model.
Peitersen T; Grunnet M; Benson AP; Holden AV; Holstein-Rathlou NH; Olesen SP
Heart Rhythm; 2008 May; 5(5):734-41. PubMed ID: 18452879
[TBL] [Abstract][Full Text] [Related]
17. Pharmacological activation of Kv11.1 in transgenic long QT-1 rabbits.
Bentzen BH; Bahrke S; Wu K; Larsen AP; Odening KE; Franke G; Storm vańs Gravesande K; Biermann J; Peng X; Koren G; Zehender M; Bode C; Grunnet M; Brunner M
J Cardiovasc Pharmacol; 2011 Feb; 57(2):223-30. PubMed ID: 21135701
[TBL] [Abstract][Full Text] [Related]
18. Pharmacological rescue of hERG currents carried out by G604S and wide type hERG co-expression.
Huo J; Zhang A; Guo X; Qiang H; Liu P; Bai L; Ma A
Clin Exp Pharmacol Physiol; 2016 Sep; 43(9):851-61. PubMed ID: 27199074
[TBL] [Abstract][Full Text] [Related]
19. Enhancement of HERG K+ currents by Cd2+ destabilization of the inactivated state.
Johnson JP; Balser JR; Bennett PB
Biophys J; 1999 Nov; 77(5):2534-41. PubMed ID: 10545354
[TBL] [Abstract][Full Text] [Related]
20. Modulation of rat erg1, erg2, erg3 and HERG K+ currents by thyrotropin-releasing hormone in anterior pituitary cells via the native signal cascade.
Schledermann W; Wulfsen I; Schwarz JR; Bauer CK
J Physiol; 2001 Apr; 532(Pt 1):143-63. PubMed ID: 11283231
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]